Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-OSA

Eli Lilly · Phase 3 · Completed · Enrollment 469

NCT05412004

EudraCT 2021-004552-41

ArmPopulationDoseWeeksEstimandWeight change
Tirzepatide MTD_GPI1Obesity or overweightn/r52n/rn/r
Placebo_GPI1Obesity or overweightn/r52n/rn/r
Tirzepatide MTD_GPI2Obesity or overweightn/r52n/rn/r
Placebo_GPI2Obesity or overweightn/r52n/rn/r